Navigation Links
Oramed Pharmaceuticals Announces Filing of Two Registration Statements
Date:1/11/2010

gistration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at Jerusalem's Hadassah Medical Center. The Company's corporate and R&D headquarters are based in Jerusalem.

For more information, please visit http://www.oramed.com

Forward-looking statements

Some of the statements contained in this press release are forward-looking statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Oramed, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval for our product candidates; competition from other pharmaceutical or biotechnology
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Societys Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA)
2. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England
3. Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009
4. Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule
5. Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New Orleans, LA)
6. Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository
7. Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Societys Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
8. Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
9. /K I L L K I L L K I L L -- Oramed Pharmaceuticals Inc./
10. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
11. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 Amgen (NASDAQ: AMGN ) will ... Conference on Thursday, May 30, 2013, at the Westin Boston ... a.m. Eastern Daylight Time. Arvind Sood , ... the conference. Live audio of the presentation can be accessed ... under Investors. A replay of the webcast will also be ...
(Date:5/23/2013)... , May 23, 2013  A recently published ... Houston, Texas , demonstrates that 3D ... increasing cancer detection. The study, "Implementation ... Observational Study," was led by Stephen L. ... issue of the American Journal of Roentgenology ...
(Date:5/23/2013)... Anthem Blue Cross patients with HIV/AIDS may ... to obtain their medications by mail order under a ... LLC.  The lawsuit, filed in January ... mandatory mail order program announced late last year illegally ... "This settlement brings to a close a nerve-racking ...
Breaking Medicine Technology:First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3
(Date:5/25/2013)... 25, 2013 This week idcloak Technologies releases ... Facebook in countries where the site is blocked. When ... faces none of the site compatibility problems associated with regular ... explains how a user may apply IP Port proxies to ... benefits of doing so are. , “When a user takes ...
(Date:5/25/2013)... Imagine running the air conditioner with the ... air and wasted energy! If the home has a folding ... clothes dryer, that may be just what is occurring in ... holes waste energy in the form of higher energy bills. ... in the home. , Drafts occur through the small cracks ...
(Date:5/25/2013)... May 25, 2013 It's not astonishing ... the year. The demands are endless, from family, friends ... buy, children who want more than their parents can ... after holiday season, comes graduations, birthdays, anniversaries and it ... some point gift ideas become tired and income can’t ...
(Date:5/25/2013)... Chandler, AZ (PRWEB) May 25, 2013 ... whitening service page in partnership with JD Media Surge, ... whitening methods are now available and, depending on the ... home. During a routine visit, the best method will ... whitening is performed during a visit. A special peroxide-based ...
(Date:5/25/2013)... Communities of Distinction TV announces May air ... media market in the United States with almost three million ... Texas and a major convention city. Ft. Worth is known ... is home to many major museums. Both cities offer a ... arts. Residents and locals will be able to watch the ...
Breaking Medicine News(10 mins):Health News:idcloak Launches Proxy Web Browser for Blocked Facebook Users 2Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 2Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 3Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 4Health News:TheBeautyPlace.com Debuts Their Brand New Beauty Kits 2Health News:Chandler Dentist Launches Teeth Whitening Service Page on Website in Partnership with JD Media Surge, LLC 2Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2
... class of drugs for treating,type 2 diabetes is under ... for Clinical Evaluative Sciences (ICES) finds that drugs such,as ... and death., Published in the December 12th issue ... drugs including rosiglitazone (Avandia) and,pioglitazone (Actos) in the first ...
... Early identification of adverse effects of drugs before they ... therapeutics, as unexpected effects account for a third of ... researchers at the University of California, San Diego (UCSD) ... identify potential side effects of pharmaceuticals, and have used ...
... -- In as many as one in five people ... blood around the body, some degree of backward leakage ... mitral regurgitation (MR). When sufficiently severe, MR causes buildup ... breathing (dyspnea, or "shortness of breath"), a serious condition ...
... predictor of heart disease, Britsh study says , TUESDAY, Dec. ... risk factor for heart disease, say British researchers who also ... of heart disease risk than waist measurement alone. , ... , included 24,508 men and women, ages 45 to 79, ...
... achievements place the field of microresonators at the ... issue of Optics Express, papers explore advanced silicon ... applications and the longest photon lifetime in a ... to Dr. Vasily Astratov from the University of ...
... is a familiar scenario experienced around the world: an outbreak ... one knows where it came from or how to stop ... people are affected, most often the very old and the ... fall ill, and people who were weak or unwell may ...
Cached Medicine News:Health News:More evidence suggests diabetes drug may be dangerous 2Health News:More evidence suggests diabetes drug may be dangerous 3Health News:New computational technique can predict drug side effects 2Health News:Exercise testing may help predict seriousness of mitral regurgitation 2Health News:Abdominal Fat Tied to High Risk for Coronary Trouble 2Health News:IBM reports milestone in silicon nanophotonics 2Health News:Scientists seek to assess the microbial risks in the water we drink 2Health News:Scientists seek to assess the microbial risks in the water we drink 3
... SofPort Advanced Optics Aspheric Lens System ... one IOL all your cataract patients ... vision quality and contrast sensitivity. With ... AO should consistently deliver superior optical ...
... Defibrillator was designed to be as easy ... and shares many of its features, including ... Philips HeartStart Home Defibrillator is an automated ... home use by untrained users. Although small ...
... Brilliance 64-channel configuration breaks through previous ... volume, thin-slice coverage to improve diagnostic ... ,With 40mm of thin-slice coverage, the ... allowing for unprecedented coronary artery evaluation. ...
Designed to meet the demanding requirements of scientific and laboratory,applications. Special cabinet incorporates industrial quality with a,heavy duty refrigeration system to maintain your valu...
Medicine Products: